Bacterial keratitis: Predisposing factors, clinical and microbiological review of 300 cases

British Journal of Ophthalmology

Volumn 87, Issue 7, 2003, Pages 834-838

  Bourcier, Tristan ^a   Thomas, F ^a   Borderie, V ^a   Chaumeil, C ^a   Laroche, L ^a  

^a CENTRE HOSPITALIER NATIONAL D OPHTALMOLOGIE DES QUINZE VINGTS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANTERIOR EYE CHAMBER DISEASE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; CHILD; CONTACT LENS; CONTROLLED STUDY; CORNEA ULCER; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; EYE INJURY; FEMALE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HOSPITAL ADMISSION; HUMAN; INFANT; INFORMATION PROCESSING; KERATITIS; KERATOPATHY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; POOR GENERAL CONDITION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; VISUAL ACUITY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; CHILD; CHILD, PRESCHOOL; CONTACT LENSES; CORNEA; CORNEAL DISEASES; EYE INJURIES; FEMALE; HUMANS; INFANT; KERATITIS; MALE; MIDDLE AGED; PSEUDOMONAS INFECTIONS; RETROSPECTIVE STUDIES; RISK FACTORS; STAPHYLOCOCCAL INFECTIONS; SUPPURATION; TREATMENT OUTCOME;

EID: 0037784221     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.87.7.834     Document Type: Article

References (27)

1. McLeod SD, LaBree LD, Tayyanipour R, et al. The importance of initial management in the treatment of severe infectious corneal ulcers. Ophthalmology 1995;102:1943-8.
2. McLeod SD, Kolahdouz-Isfahani A, Rostamian K, et al. The role of smears, cultures, and antibiotic sensitivity testing in the management of suspected infectious keratitis. Ophthalmology 1996;103:23-8.
3. Miedziak AI, Miller MR, Rapuano CJ, et al. Risk factors in microbial keratitis leading to penetrating keratoplasty. Ophthalmology 1999;106:1166-70; discussion 1171.
4. Vajpayee RB, Dada T, Saxena R, et al. Study of the first contact management profile of cases of infectious keratitis: a hospital-based study. Cornea 2000;19:52-6.
5. Benson WH, Lanier JD: Current diagnosis and treatment of corneal ulcers. Curr Opin Ophthalmol 1998;9:45-49.
6. Musch DC, Sugar A, Meyer RF. Demographic and predisposing factors in corneal ulceration. Arch Ophthalmol 1983;101:1545-8.
7. Dart JK. Predisposing factors in microbial keratitis: the significance of contact lens wear. Br J Ophthalmol 1988;72:926-30.
8. Liesegang TJ. Contact lens-related microbial keratitis: Part I: Epidemiology. Cornea 1997;16:125-31.
9. Schaefer F, Bruttin O, Zografos L, et al. Bacterial keratitis: a prospective clinical and microbiological study. Br J Ophthalmol 2001;85:842-7.
10. Baker RS, Flowers Jr CW, Casey R, et al. Efficacy of ofloxacin vs cefazolin and tobramycin in the therapy for bacterial keratitis. Arch Ophthalmol 1996;114:632-3.
11. Bennett HG, Hay J, Kirkness CM, et al. Antimicrobial management of presumed microbial keratitis: guidelines for treatment of central and peripheral ulcers. Br J Ophthalmol 1998;82:137-45.
12. Alexandrakis G, Alfonso EC, Miller D. Shifting trends in bacterial keratitis in south Florida and emerging resistance to fluoroquinolones. Ophthalmology 2000;107:1497-502.
13. Gudmundsson OG, Ormerod LD, Kenyon KR, et al. Factors influencing predilection and outcome in bacterial keratitis. Cornea 1989;8:115-21.
14. Cohen EJ, Fulton JC, Hoffman CJ, et al. Trends in contact lens-associated corneal ulcers. Cornea 1996;15:566-70.
15. Coster DJ, Badenoch PR. Host, microbial, and pharmacological factors affecting the outcome of suppurative keratitis. Br J Ophthalmol 1987;71:96-101.
16. Dart JK, Stapleton F, Minassian D. Contact lenses and other risk factors in microbial keratitis. Lancet 1991;338:650-3.
17. Erie JC, Nevitt MP, Hodge DO, et al. Incidence of ulcerative keratitls in a defined population from 1950 through 1988. Arch Ophthalmol 1993;111:1665-71.
18. Liesegang TJ. Contact lens-related microbial keratitis: Part II: Pathophysiology. Cornea 1997;16:265-73.
19. Goldstein MH, Kowalski RP, Gordon YJ. Emerging fluoroquinolone resistance in bacterial keratitis: a 5-year review. Ophthalmology 1999;106:1313-18.
20. Levey SB, Katz HR, Abrams DA, et al. The role of cultures in the management of ulcerative keratitis. Cornea 1997;16:383-6.
21. Wilhelmus KR, Hyndiuk RA, Caldwell DR, et al. 0.3% Ciprofloxacin ophthalmic ointment in the treatment of bacterial keratitis. The Ciprofloxacin Ointment/Bacterial Keratitis Study Group. Arch Ophthalmol 1993;111:1210-18.
22. O'Brien TP, Maguire MG, Fink NE, et al. Efficacy of ofloxacin vs cefazolin and tobramycin in the therapy for bacterial keratitis. Report from the Bacterial Keratitis Study Research Group. Arch Ophthalmol 1995;113:1257-65.
23. Schein OD, Ormerod LD, Barraquer E, et al. Microbiology of contact lens-related keratitis. Cornea 1989;8:281-5.
24. Gray TB, Cursons RT, Sherwan JF, et al. Acanthamoeba, bacterial, and fungal contamination of contact lens storage cases. Br J Ophthalmol 1995;79:601-5.
25. Morlet N, Minassian D, Butcher J. Risk factors for treatment outcome of suspected microbial keratitis. Ofloxacin Study Group. Br J Ophthalmol 1999;83:1027-31.
26. Killingsworth DW, Stern GA, Driebe WT, et al. Results of therapeutic penetrating keratoplasty. Ophthalmology 1993;100:534-541.
27. McDonnell PJ. Empirical or culture-guided therapy for microbial keratitis? A plea for data. Arch Ophthalmol 1996;114:84-7.